Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume 36, Issue 2, Pages 381-391
Publisher
Wiley
Online
2017-06-29
DOI
10.1002/hon.2453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study
- (2016) Klára Piukovics et al. ANNALS OF HEMATOLOGY
- Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab
- (2016) Tania Jain et al. ANNALS OF HEMATOLOGY
- How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation
- (2016) Georg Maschmeyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study
- (2016) Rena Buckstein et al. Clinical Lymphoma Myeloma & Leukemia
- Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant
- (2016) A. Mengarelli et al. JOURNAL OF INFECTION
- Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay
- (2016) Natsuko Inazawa et al. JOURNAL OF MEDICAL VIROLOGY
- Valós idejű polimeráz láncreakció alkalmazása cytomegalovirus-fertőzés és -reaktiváció nyomon követésére malignus hematológiai betegségek kemoterápiás kezelése során és autológ őssejt-transzplantációt követően
- (2016) Klára Piukovics et al. ORVOSI HETILAP
- Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine
- (2015) Thomas S. Y. Chan et al. ANNALS OF HEMATOLOGY
- A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
- (2015) Christopher R. Flowers et al. Clinical Lymphoma Myeloma & Leukemia
- Cytomegalovirus reactivation in patients with multiple myeloma
- (2015) Tetsuo Hasegawa et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cytomegalovirus Retinitis Diagnosed After Completion of Chemotherapy for Acute Lymphoblastic Leukemia in an Adolescent
- (2015) Seung Beom Han et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Cytomegalovirus Disease in Children With Acute Lymphoblastic Leukemia in the Nontransplant Setting
- (2015) Aliakbar Rahbarimanesh et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine
- (2015) Noriko Isono et al. LEUKEMIA & LYMPHOMA
- Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma
- (2015) Marina P. Siakantaris et al. NEUROLOGIST
- Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents
- (2015) R. Naithani et al. Transplant Infectious Disease
- Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma
- (2014) Tetsuo Hasegawa et al. ANNALS OF HEMATOLOGY
- Incidence and risk factors for cytomegalovirus (CMV) reactivation following autologous hematopoietic stem cell transplantation in children
- (2014) Ayad Ahmed Hussein et al. PEDIATRIC BLOOD & CANCER
- Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study
- (2014) F. Marchesi et al. Transplant Infectious Disease
- Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy
- (2013) Matthew Rong Jie Tay et al. LEUKEMIA & LYMPHOMA
- High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome Transplant Network
- (2013) F. Marchesi et al. Transplant Infectious Disease
- Cytomegalovirus Pneumonia in Hematopoietic Stem Cell Recipients
- (2013) Giovanna Travi et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Cytomegalovirus Reactivation Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Chemotherapeutics and Tandem Transplantation
- (2012) Jong Hun Kim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation
- (2012) Svetlana Chapenko et al. JOURNAL OF MEDICAL VIROLOGY
- Bendamustine can severely impair T-cell immunity against cytomegalovirus
- (2012) Toru Hosoda et al. LEUKEMIA & LYMPHOMA
- The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network
- (2011) Francesco Marchesi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine
- (2011) Seah H. Lim et al. ANNALS OF HEMATOLOGY
- Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
- (2011) H. C. Kluin-Nelemans et al. ANNALS OF ONCOLOGY
- High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for Adult T cell leukemia
- (2011) Masao Ogata et al. JOURNAL OF MEDICAL VIROLOGY
- Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
- (2011) Thomas Elter et al. LANCET ONCOLOGY
- Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
- (2011) Carlos Vallejo et al. Expert Review of Hematology
- Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- (2010) Per Ljungman et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Does rituximab increase the incidence of infectious complications? A narrative review
- (2010) Theodoros Kelesidis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus Retinitis During Chemotherapy With Rituximab Plus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone
- (2010) Edward Libby et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia
- (2010) Saveria Capria et al. JOURNAL OF MEDICAL VIROLOGY
- A systematic approach to virus–virus interactions
- (2010) T. DaPalma et al. VIRUS RESEARCH
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
- (2009) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
- Fatal ongoing human cytomegalovirus reactivation during high-dose melphalan and autologous stem cell transplantation
- (2009) Daniele Focosi et al. JOURNAL OF MEDICAL VIROLOGY
- Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
- (2008) P Ljungman et al. BONE MARROW TRANSPLANTATION
- Virus reactivation in high-risk non-Hodgkin’s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation
- (2008) Peng-Chan Lin et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started